AffiAB® Anti-POLR2A Antibody [A5F4]

https://www.affiab.com/web/image/product.template/103514/image_1920?unique=b83e256
(0 review)

CAT# AFG-HB-3193
Size: 100 μL

465.00 465.0 USD 465.00

465.00

For Price Contact info@affigen.com

This combination does not exist.

Terms and Conditions
30-day money-back guarantee
Shipping: 2-3 Business Days

AffiAB® Anti-POLR2A Antibody [A5F4]

DNA-dependent RNA polymerase catalyzes the transcription of DNA into RNA using the four ribonucleoside triphosphates as substrates. Largest and catalytic component of RNA polymerase II which synthesizes mRNA precursors and many functional non-coding RNAs. Forms the polymerase active center together with the second largest subunit. Pol II is the central component of the basal RNA polymerase II transcription machinery. It is composed of mobile elements that move relative to each other. RPB1 is part of the core element with the central large cleft, the clamp element that moves to open and close the cleft and the jaws that are thought to grab the incoming DNA template. At the start of transcription, a single-stranded DNA template strand of the promoter is positioned within the central active site cleft of Pol II. A bridging helix emanates from RPB1 and crosses the cleft near the catalytic site and is thought to promote translocation of Pol II by acting as a ratchet that moves the RNA-DNA hybrid through the active site by switching from straight to bent conformations at each step of nucleotide addition. During transcription elongation, Pol II moves on the template as the transcript elongates. Elongation is influenced by the phosphorylation status of the C-terminal domain (CTD) of Pol II largest subunit (RPB1) , which serves as a platform for assembly of factors that regulate transcription initiation, elongation, termination and mRNA processing. Regulation of gene expression levels depends on the balance between methylation and acetylation levels of tha CTD-lysines. Initiation or early elongation steps of transcription of growth-factors-induced immediate early genes are regulated by the acetylation status of the CTD. Methylation and dimethylation have a repressive effect on target genes expression.

Antibody type

Mouse monoclonal Antibody

Uniprot ID

SwissProt: P24928 Human; SwissProt: P08775 Mouse; SwissProt: D4A5A6 Rat

Recombinant

NO

Conjugation

Non-conjugated

Host

Mouse

Isotype

IgG1

Clone

A5F4

KO/KD

N/A

Species reactivity

Human, Mouse, Rat

Tested applications

WB, IHC-P, FC

Predicted species reactivity

N/A

Immunogen

Recombinant protein within human POLR2A aa 751-950 / 1, 970.

Storage

Store at +4°C after thawing. Aliquot store at -20°C. Avoid repeated freeze / thaw cycles.

Form

Liquid

Storage buffer

1*TBS (pH7.4) , 0.2% BSA, 50% Glycerol. Preservative: 0.05% Sodium Azide.

Concentration

2 mg/mL.

Purity

Protein G affinity purified.

Signal pathway

N/A

Recommended dilutions

WB: 1:500-1:2, 000 ; IHC-P: 1:100-1:500 ; FC: 1:100-1:500

Molecular Weight

217 kDa

Subcellular location

Cytoplasm, Nucleus, Chromosome.

Positive control

MCF-7 cell lysates, mouse lung tissue lysates, rat bladder tissue, SH-SY5Y.